Livzon Pharmaceutical Group ( (HK:1513) ) just unveiled an update.
Livzon Pharmaceutical Group Inc. has announced that its board of directors will meet on March 26, 2025, to review and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend, which could impact the company’s financial strategy and shareholder returns.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and sale of pharmaceutical products. The company is based in Zhuhai, China and is involved in both domestic and international markets.
YTD Price Performance: -3.48%
Average Trading Volume: 1,190
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.91B
For detailed information about 1513 stock, go to TipRanks’ Stock Analysis page.